Monitoring imatinib plasma concentrations in chronic myeloid leukemia

Imatinib has proved to be effective in the treatment of chronic myeloid leukemia, but plasma levels above 1,000 ng/mL must be achieved to optimize activity. Therapeutic drug monitoring of imatinib is useful for patients that do not present clinical response. There are several analytical methods to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Darlize Hübner, Wagner, Sandrine Comparsi, dos Santos, Tamyris Vianna, Lizot, Lilian de Lima Feltraco, Antunes, Marina Venzon, Capra, Marcelo, Linden, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415771/
https://www.ncbi.nlm.nih.gov/pubmed/23049322
http://dx.doi.org/10.5581/1516-8484.20110081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415771/
https://www.ncbi.nlm.nih.gov/pubmed/23049322
http://dx.doi.org/10.5581/1516-8484.20110081

Ejemplares similares